Skip to content

Prospective study on magnetic resonance tomography (MRI) -based molecular liver parenchyma diagnostics

Prospective study on magnetic resonance tomography (MRI) -based molecular liver parenchyma diagnostics

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012564
Enrollment
100
Registered
2017-07-18
Start date
2016-08-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K74

Interventions

Group 1: The degree of liver fibrosis / cirrhosis is determined by means of magnetic resonance tomography with hepatocyte-specific MRI contrast agent and correlated with the histological processing, t

Sponsors

University Hospital Regensburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Planned elective liver resection. Clinical indication for performing an MRI of the liver with liver-specific contrast medium for preoperative planning.

Exclusion criteria

Exclusion criteria: Known contrast agent incompatibility. Implants with ferromagnetic metals. Renal insufficiency

Design outcomes

Primary

MeasureTime frame
Presentation of the liver function by means of contrast-enhanced magnetic resonance tomography. Detection of the sensitivity and specificity of MRI-related liver parenchymal analysis. Detection of the inflammatory process of the development of liver cirrhosis

Secondary

MeasureTime frame
Comparison between clinical test methods and magnetic resonance tomographic liver parenchymal analysis. Comparison between histological and magnetic resonance tomography of hepatic parenchymal analysis

Countries

Germany

Contacts

Public ContactStefanie Hagen

University Hospital Regensburg

stafnie.hagn@ukr.de+49 941 944-7486

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026